Shares of Retrophin fell 27% after its rare disease drug candidate failed to work better than a placebo in a late-stage clinical study.
The California Life Sciences Association on Aug. 20 announced that it added nine board members, including from Amgen, DuPont Nutrition & Biosciences and Ernst & Young.
A postoperative pain anesthetic from Heron Therapeutics reduced pain intensity and the use of opioids among hernia surgery patients in a late-stage clinical trial, the company reported Aug. 20.
Prebys Cancer Center Will Be Under Partnership With MD Anderson
A professor at Sanford Burnham Prebys Medical Discovery Institute landed a $4.96 million grant to further study a preclinical program for oxygen-deprived newborns at risk of neurological disorders.
Company Suspended Development Of Its Lead Program
Complementary Expertise Being Applied to Develop Immunological Therapies
BIOTECH: CEO Irwin Is Out; CFO Jackson Named Interim Leader
Amid legal, manufacturing and financial problems Ra Medical Systems delayed the release of second quarter results.
In a July letter to insurers the California Department of Managed Care, or CDMC, fired a warning shot against association health plans, in what could have wide-reaching impacts for biotechs, life sciences trade groups and other industries.